 |
|
|
| |
Sofosbuvir and Ribavirin for the Treatment of Established Recurrent Hepatitis C Infection After Liver Transplantation: Preliminary Results of a Prospective, Multicenter Study
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
Michael Charlton1, Edward Gane2, Michael P. Manns3, Robert S. Brown Jr4,
Michael P. Curry5, Paul Kwo6, Robert Fontana7, Richard Gilroy8, Lewis Teperman9, Andrew Muir,10 John G. McHutchison11, William T. Symonds11, Jill Denning11, Lindsay McNair11, Sarah Arterburn11, Norah Terrault12, Didier Samuel13, Xavier Forns14
1Mayo Clinic, Rochester, MN; 2Auckland City Hospital, Auckland, New Zealand; 3Hannover Medical School, Hannover, Germany; 4Columbia University, New York, NY; 5Beth Israel Deaconess Medical Center, Boston, MA; 6Indiana School of Medicine, Indianapolis, IN; 7University of Michigan, Ann Arbor, MI; 8Kansas University Medical Center, Lawrence, KS; 9NYU Medical Center, New York, NY;
10Duke University Medical Center, Durham, NC; 11Gilead Sciences, Foster City, CA;12University of California, San Francisco, CA; 13Centre Hépatobiliaire, Hôpital Paul Brousse, Université Paris Sud, Villejuif, France; 14The Liver Unit, Barcelona, Spain
|
| |
|
|
|
|
|
